USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1.

MLA

Zhang, Ye, et al. “USP14 Promotes the Malignant Progression and Ibrutinib Resistance of Mantle Cell Lymphoma by Stabilizing XPO1.” International Journal of Medical Sciences, vol. 20, no. 5, Apr. 2023, pp. 616–26. EBSCOhost, https://doi.org/10.7150/ijms.80467.

APA

Zhang, Y., Lu, P., Jin, S., Zhang, J., & Zhou, Y. (2023). USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1. International Journal of Medical Sciences, 20(5), 616–626. https://doi.org/10.7150/ijms.80467

Chicago

Zhang, Ye, Peng Lu, Shenhe Jin, Jin Zhang, and Yan Zhou. 2023. “USP14 Promotes the Malignant Progression and Ibrutinib Resistance of Mantle Cell Lymphoma by Stabilizing XPO1.” International Journal of Medical Sciences 20 (5): 616–26. doi:10.7150/ijms.80467.